CPT 52204 Cystourethroscopy Reimbursement Benchmarks | OpenPayer

Summary & Overview

CPT 52204: Cystourethroscopy with Biopsy

CPT code 52204 is a key billing code in urology, representing cystourethroscopy with biopsy(s), a procedure used to diagnose and evaluate bladder and urethral conditions. This code is widely utilized in outpatient settings, including hospital outpatient departments and ambulatory surgery centers, and is recognized by major national payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.

The publication provides a comprehensive overview of 52204, including its clinical context, typical sites of service, and its role in the diagnosis of conditions such as acute cystitis, hematuria, and unspecified bladder disorders. Readers will gain insight into relevant policy updates, coding benchmarks, and the importance of accurate documentation for this procedure. The analysis also highlights common modifiers, associated taxonomies, and related CPT codes, offering a clear understanding of how 52204 fits within broader urology billing and reimbursement practices.

This summary serves as a resource for healthcare professionals, administrators, and policy analysts seeking to stay informed about national trends and requirements for cystourethroscopy with biopsy(s), ensuring clarity in coding and compliance across payer networks.

AetnaBlue Cross Blue ShieldCigna HealthMedicareUnitedHealthcareCPT 52204urologyendoscopyoutpatient servicescystourethroscopybiopsymedical billingclinical codingpolicy updatesbenchmarks

CPT Code Overview

CPT code 52204 describes cystourethroscopy with biopsy(s), a procedure performed by urologists to visually examine the bladder and urethra using an endoscope and obtain tissue samples for further analysis. This service is classified under urology (endoscopy) and is typically provided in an outpatient setting, such as a hospital outpatient department or ambulatory surgery center (ASC). The procedure is essential for diagnosing and evaluating various bladder and urethral conditions, allowing for targeted tissue sampling during endoscopic examination.

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves an adult presenting to a urology clinic or outpatient hospital setting with symptoms such as hematuria (blood in urine), urinary frequency, or signs of bladder inflammation. The urologist performs a cystourethroscopy to directly visualize the bladder and urethra. During the procedure, suspicious areas are identified and biopsies are taken for further pathological evaluation. This workflow is common for patients with acute cystitis, unexplained hematuria, or other bladder disorders.

Coding Specifications

Modifier 22: Used when the cystourethroscopy with biopsy requires significantly greater time, effort, or complexity than usual. This may occur in cases with challenging anatomy or extensive disease.

Provider Taxonomy Code	Specialty Description
`2084U0006X`	Urology
`208000000X`	Medical and Clinical Laboratory (if biopsy tissue processing, though typically pathology)

Urology (): Physicians specializing in urinary tract procedures, including cystourethroscopy.

National Reimbursement Benchmarks

Medicare's national mean rate for CPT code 52204 is $368.61, closely aligned with the BUCA (average commercial) mean rate of $372.71. Among commercial payers, UnitedHealth Group stands out with the highest mean rate at $541.97, while Aetna is the lowest at $261.15.

Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare exhibits the tightest range ($44.00), indicating relatively consistent reimbursement. In contrast, UnitedHealth Group shows the widest range ($277.81), reflecting substantial variability in rates. Cigna and BUCA also display broader ranges, while Aetna and Blue Cross Blue Shield fall in the middle.

The table and chart below present a detailed breakdown of national benchmarks for each payer.

State Benchmarks

State: Alaska1 / 50

Alaska Benchmarks

Alaska exhibits a notably wide range in reimbursement rates for CPT code 52204, with Aetna showing the largest spread between the 25th and 75th percentiles ($153.50), while UnitedHealth Group demonstrates minimal variation ($8.83). This suggests that some payers, particularly Aetna, have substantial internal rate variability, whereas others, like UnitedHealth Group, maintain more consistent pricing across providers.

Compared to national averages, all commercial payers in Alaska reimburse at significantly higher rates, with Aetna's mean rate nearly four times the national mean. The table and chart below present the full breakdown of payer-specific rates, highlighting the substantial differences in reimbursement across the state.

Key Insights for Alaska

Aetna is the highest paying payer for CPT 52204 in Alaska, with a mean rate of $984.02, while Medicare is the lowest at $355.65.
All commercial payers in Alaska reimburse at rates significantly above their respective national averages, with Aetna's mean rate nearly four times the national mean.
The rate spread is widest for Aetna ($153.50) and narrowest for UnitedHealth Group ($8.83), indicating substantial variation in commercial payer pricing.

CPT 52260: Diagnostic Cystoscopy for Interstitial Cystitis Evaluation

CPT-52277-TRANSURETHRAL-INCISION-EXTERNAL-URETHRAL-SPHINCTER

CPT 52277: Transurethral Incision of External Urinary Sphincter

CPT-52214-TRANSURETHRAL-BLADDER-URETHRAL-TISSUE-DESTRUCTION

CPT 52214: Transurethral Bladder and Urethral Tissue Destruction

CPT-52287-CYSTOSCOPIC-INTRADETRUSOR-NEUROLYTIC-INJECTION-OVERACTIVE-BLADDER

CPT 52287: Cystoscopic Intradetrusor Neurolytic Injection for Overactive Bladder

CPT-52318-CYSTOURETHROSCOPY-LARGE-BLADDER-STONE-REMOVAL

CPT 52318: Cystourethroscopy with Removal of Large Bladder Stone

CPT-52250-CYSTOSCOPIC-INTRAVESICAL-RADIOACTIVE-THERAPY-FOR-BLADDER-CANCER

CPT 52250: Cystoscopic Intravesical Radioactive Therapy for Bladder Cancer

CPT-52305-CYSTOSCOPIC-INCISION-RESECTION-BLADDER-DIVERTICULA

CPT 52305: Cystoscopic Incision or Resection of Bladder Diverticular Opening

CPT-52224-CYSTOSCOPY-LESION-DESTRUCTION-MINOR

CPT 52224: Cystoscopy with Destruction of Minor Bladder Lesion

CPT-52275-CYSTOSCOPY-INTERNAL-URETHROTOMY-STRICTURE-INCISION

CPT 52275: Cystoscopy with Internal Urethrotomy for Urethral Stricture

CPT-52283-CYSTOURETHROSCOPY-STEROID-INJECTION-URETHRAL-STRICTURE

CPT 52283: Cystourethroscopy with Steroid Injection for Urethral Stricture

Showing 1–10 of 26

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

2084U0006X

OpenPayer

Summary & Overview

CPT 52204: Cystourethroscopy with Biopsy

CPT Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

National Reimbursement Benchmarks

State Benchmarks

Alaska Benchmarks

Key Insights for Alaska

Related Codes

Related Diagnoses

Related CPT Codes

National Reimbursement Benchmarks

State Benchmarks

Alaska Benchmarks

Key Insights for Alaska

Related Codes